Skip to main content Accessibility help

Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health

  • Ruan Elliott (a1), Catalina Pico (a2), Yvonne Dommels (a3), Iwona Wybranska (a4), John Hesketh (a5) and Jaap Keijer (a3)...


To be able to perform a comprehensive and rigorous benefit-risk analysis of individual food components, and of foods, a number of fundamental questions need to be addressed first. These include whether it is feasible to detect all relevant biological effects of foods and individual food components, how such effects can confidently be categorised into benefits and risks in relation to health and, for that matter, how health can be quantified. This article examines the last of these issues, focusing upon concepts for the development of new biomarkers of health. Clearly, there is scope for refinement of classical biomarkers so that they may be used to detect even earlier signs of disease, but this approach defines health solely as the absence of detectable disease or disease risk. We suggest that the health of a biological system may better be reflected by its ability to withstand and manage relevant physiological challenges so that homeostasis is maintained. We discuss the potential for expanding the range of current challenge tests for use in conjunction with functional genomic technologies to develop new types of biomarkers of health.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health
      Available formats


Corresponding author

*Corresponding author: Dr Ruan Elliott, fax +44 (0)1603 507723, email


Hide All
1Renwick, AG, Flynn, A, Fletcher, RJ, Muller, DJ, Tuijtelaars, S & Verhagen, H (2004) Risk-benefit analysis of micronutrients. Food Chem Toxicol 42, 19031922.
2Stelling, J, Sauer, U, Szallasi, Z, Doyle, FJ 3rd & Doyle, J (2004) Robustness of cellular functions. Cell 118, 675685.
3Kitano, H, Oda, K, Kimura, T, Matsuoka, Y, Csete, M, Doyle, J & Muramatsu, M (2004) Metabolic syndrome and robustness tradeoffs. Diabetes 53, Suppl. 3, S6S15.
4Huang, CY & Ferrell, JE Jr (1996) Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 93, 1007810083.
5Lee, E, Salic, A, Kruger, R, Heinrich, R & Kirschner, MW (2003) The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 1, E10.
6Viguerie, N, Poitou, C, Cancello, R, Stich, V, Clement, K & Langin, D (2005) Transcriptomics applied to obesity and caloric restriction. Biochimie 87, 117123.
7Gerling, IC, Singh, S, Lenchik, NI, Marshall, DR & Wu, J (2006) New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol Cell Proteomics 5, 293305.
8Knoll, KE, Pietrusz, JL & Liang, M (2005) Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics 21, 222–229.
9Timmons, JA, Norrbom, J, Scheele, C, Thonberg, H, Wahlestedt, C & Tesch, P (2006) Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes. Genomics 87, 165–172.
10Fulop, AK & Falus, A (2004) Possibilities and results in the wide-scale genomic analysis of inflammation. Looking for the child among many midwives. Inflamm Res 53, 517522.
11Wybranska, I, Malczewska-Malec, M, Partyka, L, et al. . (In the press) Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR). Clin Chem Lab Med.
12Steru, L, Chermat, R, Thierry, B & Simon, P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85, 367–370.
13Dalla Man, C, Yarasheski, KE, Caumo, A, Robertson, H, Toffolo, G, Polonsky, KS & Cobelli, C (2005) Insulin sensitivity by oral glucose minimal models: validation against clamp. Am J Physiol Endocrinol Metab 289, E954–E959.
14Gutt, M, Davis, CL, Spitzer, SB, Llabre, MM, Kumar, M, Czarnecki, EM, Schneiderman, N, Skyler, JS & Marks, JB (2000) Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47, 177184.
15Meeusen, R, Piacentini, MF, Busschaert, B, Buyse, L, De Schutter, G & Stray-Gundersen, J (2004) Hormonal responses in athletes: the use of a two bout exercise protocol to detect subtle differences in (over)training status. Eur J Appl Physiol 91, 140–146.
16Porsolt, RD (1979) Animal model of depression. Biomedicine 30, 139140.
17Kussmann, M, Raymond, F & Affolter, M (2006) OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 124, 758787.
18Polley, AC, Mulholland, F, Pin, C, Williams, EA, Bradburn, DM, Mills, SJ, Mathers, JC & Johnson, IT (2006) Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res 66, 65536562.
19Brindle, JT, Antti, H, Holmes, E, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8, 1439–1444.
20Whitney, AR, Diehn, M, Popper, SJ, Alizadeh, AA, Boldrick, JC, Relman, DA & Brown, PO (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100, 18961901.
21Radich, JP, Mao, M, Stepaniants, S, et al. (2004) Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 83, 980–988.
22Eady, JJ, Wortley, GM, Wormstone, YM, Hughes, JC, Astley, SB, Foxall, RJ, Doleman, JF & Elliott, RM (2005) Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 22, 402–411.
23Walsh, MC, Brennan, L, Malthouse, JP, Roche, HM & Gibney, MJ (2006) Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 84, 531539.
24Lenz, EM, Bright, J, Wilson, ID, Morgan, SR & Nash, AF (2003) A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33, 11031115.
25van Erk, MJ, Blom, WA, van Ommen, B & Hendriks, HF (2006) High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. Am J Clin Nutr 84, 12331241.
26Mitchell, BL, Yasui, Y, Lampe, JW, Gafken, PR & Lampe, PD (2005) Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet. Proteomics 5, 22382246.
27Solanky, KS, Bailey, NJ, Beckwith-Hall, BM, Davis, A, Bingham, S, Holmes, E, Nicholson, JK & Cassidy, A (2003) Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem 323, 197–204.
28Wang, Y, Tang, H, Nicholson, JK, Hylands, PJ, Sampson, J & Holmes, E (2005) A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J Agric Food Chem 53, 191–196.
29de Boer, VC, van Schothorst, EM, Dihal, AA, van der Woude, H, Arts, IC, Rietjens, IM, Hollman, PC & Keijer, J (2006) Chronic quercetin exposure affects fatty acid catabolism in rat lung. Cell Mol Life Sci 63, 28472858.
30Mootha, VK, Lindgren, CM, Eriksson, KF, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267–273.
31Subramanian, A, Tamayo, P, Mootha, VK, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 1554515550.
32Kim, SY & Volsky, DJ (2005) PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6, 144.
33Majumder, PK, Febbo, PG, Bikoff, R, et al. (2004) mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 10, 594–601.
34Tian, L, Greenberg, SA, Kong, SW, Altschuler, J, Kohane, IS & Park, PJ (2005) Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A 102, 1354413549.
35Saxena, V, Orgill, D & Kohane, I (2006) Absolute enrichment: gene set enrichment analysis for homeostatic systems. Nucleic Acids Res 34, e151.
36Laaksonen, R, Katajamaa, M, Paiva, H, et al. (2006) A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS ONE 1, e97.
37Diaz-Uriarte, R & Alvarez de Andres, S (2006) Gene selection and classification of microarray data using random forest. BMC Bioinformatics 7, 3.
38Nicholson, JK, Holmes, E, Lindon, JC & Wilson, ID (2004) The challenges of modeling mammalian biocomplexity. Nat Biotechnol 22, 12681274.
39Kresnowati, MT, van Winden, WA, Almering, MJ, et al. (2006) When transcriptome meets metabolome: fast cellular responses of yeast to sudden relief of glucose limitation. Mol Syst Biol 2, 49.
40Rantalainen, M, Cloarec, O, Beckonert, O, et al. (2006) Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J Proteome Res 5, 2642–2655.
41Ippolito, JE, Xu, J, Jain, S, Moulder, K, Mennerick, S, Crowley, JR, Townsend, RR & Gordon, JI (2005) An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci U S A 102, 99019906.
42Dieck, HT, Doring, F, Fuchs, D, Roth, HP & Daniel, H (2005) Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr 135, 199205.
43Vignali, DA (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243, 243255.
44Weindruch, R & Sohal, RS (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 337, 986–994.
45Fontana, L, Meyer, TE, Klein, S & Holloszy, JO (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101, 66596663.
46Meyer, TE, Kovacs, SJ, Ehsani, AA, Klein, S, Holloszy, JO & Fontana, L (2006) Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol 47, 398–402.
47Vitousek, KM, Gray, JA & Grubbs, KM (2004) Caloric restriction for longevity: I Paradigm, protocols and physiological findings in animal research. Eur Eat Disorders Rev 12, 279–299.
48Villareal, DT, Fontana, L, Weiss, EP, Racette, SB, Steger-May, K, Schechtman, KB, Klein, S & Holloszy, JO (2006) Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial. Arch Intern Med 166, 25022510.
49Weiss, EP, Racette, SB, Villareal, DT, Fontana, L, Steger-May, K, Schechtman, KB, Klein, S, Ehsani, AA & Holloszy, JO (2006) Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss. J Appl Physiol 102, 634640.
50Harano, Y, Miyawaki, T, Nabiki, J, Shibachi, M, Adachi, T, Ikeda, M, Ueda, F & Nakano, T (2006) Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr J 53, 173–180.
51Lau, C & Rogers, JM (2004) Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Res C Embryo Today 72, 300–312.
52Schwartz, J & Morrison, JL (2005) Impact and mechanisms of fetal physiological programming. Am J Physiol Regul Integr Comp Physiol 288, R11–R15.
53Drake, AJ & Walker, BR (2004) The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol 180, 1–16.
54Wojdacz, TK & Hansen, LL (2006) Techniques used in studies of age-related DNA methylation changes. Ann N Y Acad Sci 1067, 479–487.
55Adrien, LR, Schlecht, NF, Kawachi, N, et al. (2006) Classification of DNA methylation patterns in tumor cell genomes using a CpG island microarray. Cytogenet Genome Res 114, 16–23.
56Schumacher, A, Kapranov, P, Kaminsky, Z, et al. (2006) Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res 34, 528542.
57Ottobrini, L, Ciana, P, Biserni, A, Lucignani, G & Maggi, A (2006) Molecular imaging: a new way to study molecular processes in vivo. Mol Cell Endocrinol 246, 69–75.
58Bhatnagar, A, Hustinx, R & Alavi, A (2000) Nuclear imaging methods for non-invasive drug monitoring. Adv Drug Deliv Rev 41, 4154.
59Freitas, RA (2005) Nanotechnology, nanomedicine and nanosurgery. Intl J Surgery 3, 14.



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed